Topadur Pharma

Time 2020-12-09 13:04:30

Web Name: Topadur Pharma

WebSite: http://www.topadur.com

ID:128589

Keywords:

Topadur,Pharma,

Description:

Topadur PharmaAbout usOur ApproachDisease AreasPipelineInvestorsNewsCareersContactENDEAbout usOur ApproachDisease AreasPipelineInvestorsNewsCareersContactENDEAbout usOur ApproachDisease AreasPipelineInvestorsNewsCareersContactENDEAbout usOur ApproachDisease AreasPipelineInvestorsNewsCareersContactENDEWho we areTOPADUR Pharma AG is a Swiss biopharmaceutical start-up based in Schlieren, Zurich. The company was founded in 2015 by experienced scientists that combine several years of expertise in R D Pharma. We strive for significant improvement of patients’ quality of life while providing sustainable high growth value for investors and employees.About usWHAT WE DOThe company has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency.PipelineWHAT WE SOLVEBased on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases. They stimulate capillary blood flow with unprecedented potency and efficacy, and address the problems caused by endothelial dysfunction.Our Approachlatest newsPress Release – November 10, 2020TOPADUR announces positive results from an interim analysis of Phase I trialTOPADUR announces positive results from an interim analysis of Phase I clinical trial with their new wound healing drug candidate. Read MoreTOPADUR Pharma AG: From Idea to SolutionWe are enhancing quality of life through ground-breaking research.About usOur dual-mode of action drugs target the cGMP-Enzyme Regulation System.Our ApproachDiscover our pipeline where we provide you with an overview of all major projects at TOPADUR.PipelinecGMP-Enzyme Regulation SystemProblemAging processes are characterized by a reduction in blood circulation and dysregulation in cell-cell communication. The misbalance of cGMP levels leads to diseases like chronic wounds, skin fibrosis, glaucoma, colorectal cancer, hair loss and skin aging. SolutionTOPADUR designed new drugs that target the cGMP-Enzyme Regulation System. TOPADUR’s compounds regulate the activity of sGC and PDE5 enzymes to increase the level of cGMP. This ultimately enables blood circulation and corrects the insufficient cell-cell communication. News10.11.2020Press ReleaseTOPADUR announces positive results from an interim analysis of Phase I trialTOPADUR announces positive results from an interim analysis of Phase I clinical trial with their new wound healing drug candidate. Read more27.10.2020NewsScientific Publication in ChimiaTOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds.Read more8.10.2020NewsInterview with Reto Naef, CEO of TOPADUR PHARMA AGThe Switzerland Global Enterprise interviewed Reto Naef, CEO of TOPADUR PHARMA AG.Read moreGo to NewsWhat drives usLuziaResearch DevelopmentI greatly appreciate the collaborative nature of the projects at TOPADUR where my contribution and ideas make a difference.EsraResearch DevelopmentBeing part of TOPADUR from the beginning, experiencing its growth and contributing to its success has been a privilege. With exciting projects and results, TOPADUR is an attractive workplace.RitaProject ManagementI am inspired by TOPADUR s commitment to developing new drugs that will have a meaningful impact on peoples’ lives.MichaelResearch DevelopmentTOPADUR’s entrepreneurial spirit enables me to combine conceptual work with practical application in the laboratory and thus create something meaningful.TobiasResearch DevelopmentWith a team of highly passionate people with various specialist skills and background, Topadurians develop together innovative therapeutic options with a common goal of helping patients in need.GiancarloITTaking part in the development of TOPADUR and seeing its progress motivates me.AwardsInvestorsInvestorsNews EventsPresentations DocumentsAbout usVisionHistoryLeadershipBoard of DirectorsResearch PartnersPipelineWound HealingSkin FibrosisOphthalmologyMedical cosmeticsOncologyLung Fibrosis‍Contactinfo@topadur.com+41 44 755 44 66Topadur Pharma AGGrabenstrasse 11A8952 Schlieren, SwitzerlandImpressumLegal Disclaimer

TAGS:Topadur Pharma 

<<< Thank you for your visit >>>

Hot Websites